Factors underlying the development of chronic temporal lobe epilepsy in autoimmune encephalitis.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 04 07 2018
revised: 01 10 2018
accepted: 29 10 2018
pubmed: 18 11 2018
medline: 23 7 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Limbic encephalitis (LE) is an autoimmune condition characterized by amnestic syndrome, psychiatric features and seizures. Early diagnosis and prompt treatment are crucial to avoid long-term sequelae, including psycho-cognitive deficits and persisting seizures. The aim of our study was to analyze the characteristics of 33 LE patients in order to identify possible prognostic factors associated with the development of chronic epilepsy. This is a retrospective cohort study including adult patients diagnosed with LE in the period 2010-2017 and followed up for ≥12 months. Demographics, seizure semiology, EEG pattern, MRI features, CSF/serum findings were reviewed. All 33 LE patients (19 M/14F, mean age 61.2 years) presented seizures. Thirty subjects had memory deficits; 22 presented behavioural/mood disorders. Serum and/or CSF auto-antibodies were detected in 12 patients. In 31 subjects brain MRI at onset showed typical alterations involving temporal lobes. All patients received immunotherapy. At follow-up, 13/33 had developed chronic epilepsy; predisposing factors included delay in diagnosis (p = .009), low seizure frequency at onset (p = .02), absence of amnestic syndrome (p = .02) and absence/rarity of inter-ictal epileptic discharges on EEG (p = .06). LE with paucisymptomatic electro-clinical presentation seemed to be associated to chronic epilepsy more than LE presenting with definite and severe "limbic syndrome".

Identifiants

pubmed: 30447604
pii: S0022-510X(18)30446-5
doi: 10.1016/j.jns.2018.10.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-107

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Sara Casciato (S)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Alessandra Morano (A)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Jinane Fattouch (J)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Martina Fanella (M)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Federica Avorio (F)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Mariarita Albini (M)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Luca Manfredi Basili (LM)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Emanuele Cerulli Irelli (E)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Alessandro Viganò (A)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Marco De Risi (M)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Liliana G Grammaldo (LG)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Alfredo D'Aniello (A)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Addolorata Mascia (A)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Mario Manfredi (M)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Pierpaolo Quarato (P)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Anna Teresa Giallonardo (AT)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy.

Giancarlo Di Gennaro (G)

IRCCS "NEUROMED", Pozzilli (IS), Italy.

Carlo Di Bonaventura (C)

Epilepsy Unit, Department of Neurosciences/Mental Health, "Sapienza" University, Rome, Italy. Electronic address: c_dibonaventura@yahoo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH